GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Shiller PE Ratio

Replek AD (XMAE:REPL) Shiller PE Ratio : 26.64 (As of Dec. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Replek AD Shiller PE Ratio?

As of today (2024-12-11), Replek AD's current share price is MKD15498.00. Replek AD's E10 for the quarter that ended in Sep. 2024 was MKD581.73. Replek AD's Shiller PE Ratio for today is 26.64.

The historical rank and industry rank for Replek AD's Shiller PE Ratio or its related term are showing as below:

XMAE:REPL' s Shiller PE Ratio Range Over the Past 10 Years
Min: 2.31   Med: 5.47   Max: 26.64
Current: 26.64

During the past years, Replek AD's highest Shiller PE Ratio was 26.64. The lowest was 2.31. And the median was 5.47.

XMAE:REPL's Shiller PE Ratio is ranked better than
51.18% of 465 companies
in the Drug Manufacturers industry
Industry Median: 26.16 vs XMAE:REPL: 26.64

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Replek AD's adjusted earnings per share data for the three months ended in Sep. 2024 was MKD-82.651. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is MKD581.73 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Replek AD Shiller PE Ratio Historical Data

The historical data trend for Replek AD's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD Shiller PE Ratio Chart

Replek AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.13 15.36

Replek AD Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.29 15.95 15.36 - 25.77

Competitive Comparison of Replek AD's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Replek AD's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Replek AD's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Replek AD's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Replek AD's Shiller PE Ratio falls into.



Replek AD Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Replek AD's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=15498.00/581.73
=26.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Replek AD's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Replek AD's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-82.651/133.0289*133.0289
=-82.651

Current CPI (Sep. 2024) = 133.0289.

Replek AD Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 63.201 100.560 83.608
201409 50.831 100.428 67.332
201412 62.396 99.070 83.784
201503 74.931 99.621 100.059
201506 46.080 100.684 60.883
201509 138.657 100.392 183.735
201512 95.586 99.792 127.422
201603 52.458 100.470 69.458
201606 109.082 101.688 142.702
201609 74.155 101.861 96.845
201612 184.344 101.863 240.746
201703 72.855 102.862 94.221
201706 94.209 103.349 121.264
201709 164.333 104.136 209.929
201712 166.883 104.011 213.441
201803 129.904 105.290 164.128
201806 94.838 106.317 118.666
201809 104.271 106.507 130.236
201903 85.000 107.251 105.430
201906 116.686 108.070 143.635
201909 127.616 108.329 156.713
201912 187.398 108.420 229.933
202003 0.000 108.902 0.000
202006 0.000 108.767 0.000
202009 195.671 109.815 237.034
202012 176.316 109.897 213.429
202103 296.231 111.754 352.624
202106 153.067 114.631 177.633
202109 43.283 115.734 49.751
202112 27.454 117.630 31.048
202203 203.912 121.301 223.627
202206 -40.235 125.017 -42.814
202209 -16.474 125.227 -17.500
202212 168.912 125.222 179.443
202303 73.272 127.348 76.541
202306 192.955 128.729 199.401
202309 -21.632 129.860 -22.160
202312 838.075 129.419 861.449
202406 0.000 132.554 0.000
202409 -82.651 133.029 -82.651

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Replek AD  (XMAE:REPL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Replek AD Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Replek AD's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Replek AD Business Description

Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.